Evaluation of a Short Course of Gamma Tocopherol Supplementation in Adult Subjects

Completed · Not applicable

Conditions studied: Gamma Tocopherol Serum Levels

In brief

To evaluate serum levels of gamma tocopherol and it's metabolites after 3 doses, each separated by 12 hours.

Key facts

Study ID

NCT02610829

Run by

University of North Carolina, Chapel Hill

People needed

10

Starts

2015-11-01

Expected to finish

2016-02-01

Last updated by the study team

2018-04-27

Who can join

Age: 18 and older, up to 50. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Males and females between 18 and 50 years of age.
• Vital signs within normal limits on admission to the study: SpO2 > 94%, systolic blood pressure between 150-90 mm Hg, diastolic blood pressure between 100-60 mm Hg, afebrile.

You may not qualify if…

• Any chronic medical condition considered by the PI as a contraindication to receiving yT, including significant cardiovascular disease, diabetes requiring medication, chronic renal disease, chronic thyroid disease, kidney disease or coagulation defects.
• Use of systemic or inhaled steroids.
• Use of NSAID or ASA within 48 hours of dosing, and inability to withhold these medications for the duration of the study.
• Use of anticoagulants including warfarin, heparin, clopidogrel or enoxaparin.
• Diagnosis of anemia or abnormal blood counts at screening
• Known vagal response to venipuncture
• Abnormal PT or PTT values at screening.
• BMI > 35
• Pregnant or breast feeding women will not be included.

Where it is running

• Center for Environmental Medicine, Asthma and Lung Biology — Chapel Hill, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.